ATF3 and fatty liver disease: By decreasing ATF3, cardiolipin synthase 1 (CRLS1), a member of the cytidine diphosphate-alcohol phosphatidyl transferase class-I family, decreases insulin resistance, hepatic steatosis, inflammation, and fibrosis.72